Dissemin is shutting down on January 1st, 2025

Published in

Taylor and Francis Group, Leukemia & Lymphoma, p. 1-10, 2024

DOI: 10.1080/10428194.2024.2322030

Links

Tools

Export citation

Search in Google Scholar

An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study

Journal article published in 2024 by Aurore Perrot ORCID, Sosana Delimpasi ORCID, Emmanouil Spanoudakis ORCID, Ulf Frølund, Angelo Belotti, Albert Oriol ORCID, Philippe Moreau ORCID, Ian McFadden ORCID, Qing Xia ORCID, Mukta Arora ORCID, Meletios Athanasios Dimopoulos ORCID
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO